A detailed history of Baird Financial Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Baird Financial Group, Inc. holds 545,547 shares of BMY stock, worth $31.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
545,547
Previous 574,250 5.0%
Holding current value
$31.5 Million
Previous $23.8 Million 18.38%
% of portfolio
0.06%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$39.66 - $51.75 $1.14 Million - $1.49 Million
-28,703 Reduced 5.0%
545,547 $28.2 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $11 Million - $14.4 Million
-272,404 Reduced 32.17%
574,250 $23.8 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $2.76 Million - $3.13 Million
-57,512 Reduced 6.36%
846,654 $45.9 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $7.73 Million - $9.22 Million
-159,405 Reduced 14.99%
904,166 $46.4 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $729,298 - $815,468
12,598 Added 1.2%
1,063,571 $61.7 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $2.56 Million - $2.84 Million
-40,112 Reduced 3.68%
1,050,973 $67.2 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $280,581 - $318,243
-4,270 Reduced 0.39%
1,091,085 $75.6 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $3 - $1,921
-25 Reduced -0.0%
1,043,760 $74.2 Million
Q2 2022

Aug 08, 2022

SELL
$72.62 - $79.98 $16.8 Million - $18.5 Million
-231,590 Reduced 18.16%
1,043,785 $80.4 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $3.58 Million - $4.29 Million
-58,254 Reduced 4.37%
1,275,375 $93.1 Million
Q4 2021

Feb 09, 2022

SELL
$53.63 - $62.52 $10.5 Million - $12.2 Million
-195,439 Reduced 12.78%
1,333,629 $83.2 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $3.85 Million - $4.51 Million
65,023 Added 4.44%
1,529,068 $90.5 Million
Q2 2021

Aug 11, 2021

BUY
$61.91 - $67.42 $312,521 - $340,336
5,048 Added 0.35%
1,464,045 $97.8 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $4.63 Million - $5.2 Million
77,949 Added 5.64%
1,458,997 $92.1 Million
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $4.04 Million - $4.58 Million
69,944 Added 5.33%
1,381,048 $85.7 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $8.38 Million - $9.29 Million
145,976 Added 12.53%
1,311,104 $79 Million
Q2 2020

Oct 22, 2020

BUY
$54.82 - $64.09 $6.11 Million - $7.15 Million
111,541 Added 10.59%
1,165,128 $67.7 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $4.1 Million - $4.79 Million
-74,757 Reduced 6.63%
1,053,587 $65.6 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $3.12 Million - $4.53 Million
67,240 Added 6.34%
1,128,344 $62.9 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $5.41 Million - $7.06 Million
109,960 Added 11.56%
1,061,104 $68.1 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $4.65 Million - $5.51 Million
-108,636 Reduced 10.25%
951,144 $48.2 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $16.4 Million - $18.1 Million
367,528 Added 53.09%
1,059,780 $48.1 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $4.7 Million - $5.61 Million
104,220 Added 17.72%
692,252 $33 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $2.5 Million - $3.24 Million
-51,245 Reduced 8.02%
588,032 $30.6 Million
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $23,621 - $26,643
428 Added 0.07%
639,277 $39.7 Million
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $1.01 Million - $1.26 Million
19,927 Added 3.22%
638,849 $35.4 Million
Q1 2018

May 14, 2018

BUY
$59.92 - $68.98 $931,276 - $1.07 Million
15,542 Added 2.58%
618,922 $39.1 Million
Q4 2017

Feb 09, 2018

BUY
$59.94 - $65.35 $612,766 - $668,073
10,223 Added 1.72%
603,380 $37 Million
Q3 2017

Nov 14, 2017

SELL
$55.23 - $63.74 $4.28 Million - $4.94 Million
-77,510 Reduced 11.56%
593,157 $37.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
670,667
670,667 $37.4 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.